🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/09/2009 | 29,78 | 30,94 | 29,60 | 30,56 | +2,50% | 4,49% | 15.006.941 |
| 25/09/2009 | 29,49 | 30,26 | 29,49 | 29,82 | +0,77% | 2,59% | 22.122.442 |
| 24/09/2009 | 29,80 | 29,96 | 29,39 | 29,59 | -1,02% | 1,92% | 16.095.079 |
| 23/09/2009 | 29,95 | 30,15 | 29,73 | 29,90 | +0,00% | 1,40% | 21.497.834 |
| 22/09/2009 | 30,37 | 30,37 | 29,86 | 29,90 | -1,54% | 1,70% | 14.417.546 |
| 21/09/2009 | 30,33 | 30,61 | 30,15 | 30,36 | -0,19% | 1,51% | 14.210.251 |
| 18/09/2009 | 30,71 | 30,88 | 30,32 | 30,42 | -0,41% | 1,80% | 21.274.086 |
| 17/09/2009 | 30,56 | 30,89 | 30,26 | 30,54 | -0,50% | 2,06% | 15.921.426 |
| 16/09/2009 | 31,23 | 31,27 | 30,40 | 30,70 | -1,62% | 2,78% | 15.582.712 |
| 15/09/2009 | 31,32 | 31,41 | 31,11 | 31,20 | -0,58% | 0,97% | 16.012.602 |
| 14/09/2009 | 30,86 | 31,42 | 30,82 | 31,38 | +1,08% | 1,95% | 19.285.296 |
| 11/09/2009 | 30,68 | 31,13 | 30,46 | 31,05 | +1,81% | 2,18% | 15.100.108 |
| 10/09/2009 | 30,20 | 30,60 | 29,84 | 30,50 | +1,30% | 2,53% | 15.584.913 |
| 09/09/2009 | 29,68 | 30,17 | 29,48 | 30,11 | +1,87% | 2,35% | 13.018.780 |
| 08/09/2009 | 29,51 | 29,61 | 28,91 | 29,55 | +0,88% | 2,36% | 14.400.358 |
| 04/09/2009 | 29,06 | 29,29 | 28,83 | 29,29 | +1,52% | 1,61% | 12.744.309 |
| 03/09/2009 | 29,42 | 29,46 | 28,57 | 28,86 | -1,85% | 3,02% | 17.347.754 |
| 02/09/2009 | 29,93 | 29,96 | 29,34 | 29,40 | -3,08% | 2,07% | 14.240.853 |
| 01/09/2009 | 30,81 | 31,04 | 30,21 | 30,33 | -1,97% | 2,69% | 16.841.465 |
| 31/08/2009 | 30,79 | 31,19 | 30,69 | 30,94 | +0,34% | 1,64% | 13.569.294 |
| 28/08/2009 | 31,41 | 31,41 | 30,65 | 30,84 | -1,67% | 2,43% | 12.640.452 |
| 27/08/2009 | 31,11 | 31,49 | 30,73 | 31,36 | +0,58% | 2,42% | 10.302.154 |
| 26/08/2009 | 31,32 | 31,47 | 30,98 | 31,18 | -0,82% | 1,55% | 10.438.080 |
| 25/08/2009 | 31,40 | 31,54 | 31,01 | 31,44 | +1,38% | 1,67% | 20.081.566 |
| 24/08/2009 | 31,48 | 31,49 | 30,83 | 31,01 | -0,18% | 2,09% | 14.227.229 |
| 21/08/2009 | 30,20 | 31,22 | 30,01 | 31,07 | +3,89% | 4,01% | 21.721.372 |
| 20/08/2009 | 30,19 | 30,19 | 29,56 | 29,90 | -0,44% | 2,09% | 16.164.562 |
| 19/08/2009 | 29,26 | 30,46 | 29,06 | 30,04 | +2,51% | 4,79% | 21.322.294 |
| 18/08/2009 | 29,46 | 29,46 | 28,91 | 29,30 | -0,55% | 1,85% | 12.926.032 |
| 17/08/2009 | 29,20 | 29,91 | 29,14 | 29,47 | -0,32% | 2,65% | 19.584.290 |